Search research articles
Contact Us
Filters
Showing results (211-220 of 953) with videos related to
Page
of 96
Sort By:
Radiology
|
June 25, 2008
Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients
Jasper D Sluimer, Wiesje M van der Flier, Giorgos B Karas, et al.
Neurobiology of Aging
|
August 12, 2008
Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study
Jasper D Sluimer, Femke H Bouwman, Hugo Vrenken, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Vorapun Senanarong, Tanyaluck Thientunyakit, Chatchawan Rattanabannakit, et al.
Lancet (London, England)
|
February 28, 2016
Alzheimer's disease
Philip Scheltens, Kaj Blennow, Monique M B Breteler, et al.
Neurobiology of Aging
|
May 21, 2015
Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease
Rik Ossenkoppele, Niklas Mattsson, Charlotte E Teunissen, et al.
The Lancet. Neurology
|
September 19, 2019
Re-aligning scientific and lay narratives of Alzheimer's disease
Giovanni B Frisoni, Craig Ritchie, Emmanuel Carrera, et al.
Neuroradiology
|
October 24, 2007
Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study
Giorgos Karas, Philip Scheltens, Serge Rombouts, et al.
Neuroimage
|
January 18, 2005
Noradrenaline mediates amygdala activation in men and women during encoding of emotional material
Anda H van Stegeren, Rutger Goekoop, Walter Everaerd, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 23, 2009
Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease
Nelleke Tolboom, Maqsood Yaqub, Ronald Boellaard, et al.
Archives of Neurology
|
April 12, 2006
Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease
Daniela Galimberti, Niki Schoonenboom, Philip Scheltens, et al.
Page
of 96
Search research articles
Search
Showing results (211-220 of 953) with videos related to
Sort By:
Page
of 96
Radiology
|
June 25, 2008
Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients
Jasper D Sluimer, Wiesje M van der Flier, Giorgos B Karas, et al.
Neurobiology of Aging
|
August 12, 2008
Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study
Jasper D Sluimer, Femke H Bouwman, Hugo Vrenken, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Vorapun Senanarong, Tanyaluck Thientunyakit, Chatchawan Rattanabannakit, et al.
Lancet (London, England)
|
February 28, 2016
Alzheimer's disease
Philip Scheltens, Kaj Blennow, Monique M B Breteler, et al.
Neurobiology of Aging
|
May 21, 2015
Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease
Rik Ossenkoppele, Niklas Mattsson, Charlotte E Teunissen, et al.
The Lancet. Neurology
|
September 19, 2019
Re-aligning scientific and lay narratives of Alzheimer's disease
Giovanni B Frisoni, Craig Ritchie, Emmanuel Carrera, et al.
Neuroradiology
|
October 24, 2007
Precuneus atrophy in early-onset Alzheimer's disease: a morphometric structural MRI study
Giorgos Karas, Philip Scheltens, Serge Rombouts, et al.
Neuroimage
|
January 18, 2005
Noradrenaline mediates amygdala activation in men and women during encoding of emotional material
Anda H van Stegeren, Rutger Goekoop, Walter Everaerd, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 23, 2009
Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease
Nelleke Tolboom, Maqsood Yaqub, Ronald Boellaard, et al.
Archives of Neurology
|
April 12, 2006
Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease
Daniela Galimberti, Niki Schoonenboom, Philip Scheltens, et al.
Page
of 96